SIO2022 Program

Click here to view IO Essentials Programming.

*TARE Master Class Part 1: Radiation Physics and Pre-procedure Work-up

Moderators: Daniel Sze, MD, PhD, Stanford University, USA; Nora Tabori, MD, MedStar Washington Hospital, USA

• Y90 Radiation Physics and Cancer Biology, Andrew Kennedy, MD, FACRO, Sarah Cannon, USA
• Patient Selection and Clinical Evaluation: HCC, R. Peter Lokken, MD, MPH, FSIR, UCSF, USA
• Patient Selection and Clinical Evaluation: Metastatic disease, David Mauro, MD, University of North Carolina, USA
• Mapping Angiography, Protective Embolization, Anti-reflux Catheters, and Cone Beam CT, Daniel Sze, MD, PhD, Stanford University, USA
• Tc-99m MAA Shunt Study: Determining tumor to normal liver perfusion ratio, S. Cheenu Kappadath, PhD, UT MD Anderson Cancer Center, USA: 
• Strategies for High Lung Shunt Fraction, John Louie, MD, Stanford University, USA

*TARE Master Class Part 2: TARE for HCC

Moderators: Robert Lewandowski, MD, FSIR, Northwestern Medicine, USA; Siddharth Padia, MD, UCLA, USA

• Product Selection: Y90 glass vs. resin, Daniel Sze, MD, PhD, Stanford University, USA
• Holmium 166 Primer for Non-users, Marnix Lam, MD, PhD, University Medical Center Utrecht, Netherlands
• HCC Applications and Dosimetry: Radiation segmentectomy, Siddharth Padia, MD, UCLA, USA 
• HCC Applications and Dosimetry: Radiation lobectomy, Robert Lewandowski, MD, FSIR, Northwestern Medicine, USA
• HCC Applications and Dosimetry: Macrovascular invasion, Beau Toskich, MD, Mayo Clinic, USA
• HCC Applications and Dosimetry: Multifocal disease, Suvranu Ganguli, MD, Boston Medical Center/Boston University of Medicine, USA

*TARE Master Class Part 3: TARE for Liver Metastases

Moderators: Charles Nutting, DO, FSIR, ECCO Medical, USA; Amy Deipolyi, MD, PhD, West Virginia University, USA

• Metastatic Disease: Y90 treatment strategies, Charles Nutting, DO, FSIR, ECCO Medical, USA
• Y90 Resin Dosimetry: Optimization of tumor and liver parenchyma dose, S. Cheenu Kappadath, PhD, UT MD Anderson Cancer Center, USA
• Same Day Mapping and Treatment, Riad Salem, MD, MBA, Northwestern University, USA
• Radiation Sensitizers, Colette Shaw, Associate Professor of Radiology, Thomas Jefferson University Hospital, USA
• Mitigation of Radioembolization Risks, Amy Deipolyi, MD, PhD, West Virginia University, USA

*TARE Master Class Part 4: M&M

Moderators: Philippe Pereira, MD, SLK Kliniken, Germany; Riad Salem, MD, MBA, Northwestern University, USA 

• M&M Save, Susan Shamimi-Noor, MD, University of Pennsylvania, USA
• M&M Disaster, Beau Toskich, MD, Mayo Clinic, USA
• M&M Save, Michael Heller, MD, UCSF, USA
• M&M Disaster, Charles Nutting, ECCO Medical, USA
• M&M Save, Siddharth Padia, MD, UCLA, USA
• M&M Disaster, Collette Shaw, Associate Professor of Radiology, Thomas Jefferson University Hospital, USA

*An additional fee is required to attend the TARE Master Class.

Welcome and Dr. Sidney Wallace and Dr. Michael J. Wallace Distinguished Lecture

Riad Salem, MD, MBA, Northwestern University, USA

HCC

Moderators: Robert Lewandowski, MD, FSIR, Northwestern Medicine, USA; Isabel Newton, MD, PhD, VA San Diego Healthcare System and UC San Diego, USA 

• Changing Landscape of Systemic Therapies for HCC, John Gordan, MD, UCSF, USA
• LIRADS: Therapeutic response, Claude Sirlin, MD, Liver Imaging Group, Dep. of Radiology, UCSD, USA
• Harnessing Tumor Metabolism to Overcome Loco-regional Therapy Failures, Terence Gade, MD, PhD, Penn Image-Guided Interventions Lab, University of Pennsylvania, USA
• Compete or Combine: Lessons from the Imbrave-150 trial, Riccardo Lencioni, MD, University of Pisa School of Medicine, Italy
• Beyond the Algorithm: How to choose the best LRT, Nadine Abi Jaoudeh, MD, FSIR, CCRP, University of California Irvine, USA
• Evolution of Radioembolization in HCC: Big doses, small places, Nora Tabori, MD, MedStar Washington Hospital Center, USA
• Latest Trends in Ablation, Laura Crocetti, Prof., MD, PhD, University of Pisa School of Medicine, Italy

Ethics of Consent in IR

Presented in partnership with The Interventional Initiative

• Patient Decision Aids to Improve Patient Care in IO, Eric Keller, MD, MA, Stanford University, USA

Pain Palliation

Moderators: Sean Tutton, MD, FSIR, FCIRSE, UCSD, USA; Dimitrios Filippiadis, University of Athens, Greece

• Pharmacological Management of Cancer Pain in 2022, Paul Lindenfeld, MD, UCSF, USA
• Nerve Blocks and Steroid Injections for Cancer Pain, Dan Nguyen, MD, Neuroradiology & Pain Solutions of Oklahoma, USA
• Percutaneous Neurolysis in 2022: Facing the challenges, J. David Prologo, MD, FSIR, ABOM-D, Emory University School of Medicine, USA
• Multidisciplinary Approach to Cancer Pain with Combination Treatment, Sean Tutton, MD, FSIR, FCIRSE, UCSD, USA
• The Role of Percutaneous Ablation in the Palliation of Cancer Pain, Alan Sag, MD, Duke University Medical Center, USA

Complex Cases

Moderators: Edward Kim, MD, Mount Sinai Health Systems, USA; Stephen Solomon, MD, Memorial Sloan Kettering Cancer Center, USA; Matthew Callstrom, MD, PhD, Mayo Clinic, USA

Moderators will bring cases for discussion.

Controversies

Moderators: David Breen, MD, University Hospital Southampton, UK; William Rilling, MD, FSIR, Medical College Wisconsin, USA

• Painful Pelvic Metastasis: Radiotherapy or ablation?, A. Nick Kurup, MD, Associate Professor of Radiology, Mayo Clinic, USA v. Mary Feng, MD, UCSF, USA
• PVE vs. Double Venous Deprivation: Why?, Daniel Brown, MD, Vanderbilt University Medical Center, USA v. Alban Denys, Pr. CHUV University of Lausanne, USA
• Peripheral Colorectal Lung Mets: SBRT vs. ablation, Thierry de Baere, MD, Gustave Roussy, France v. Abraham Wu, MD, Memorial Sloan Kettering Cancer Center, USA
• Intermediate HCC: The shifting TACE and systemic therapy interface, Robert Lewandowski, MD, FSIR, Northwestern Medicine, USA, v. Laura Crocetti, Prof., MD, PhD, University of Pisa School of Medicine, Italy

HCC Tumor Board

Moderators: Robert Lewandowski, MD, FSIR, Northwestern Medicine, USA; Isabel Newton, MD, PhD, VA San Diego Healthcare System and UC San Diego, USA 

Case Discussions:

• John Gordan, MD, UCSF, USA
• Claude Sirlin, MD, Liver Imaging Group, Dep. of Radiology, UCSD, USA
• Terence Gade, MD, PhD, Penn Image-Guided Interventions Lab, University of Pennsylvania, USA
• Riccardo Lencioni, MD, University of Pisa School of Medicine, Italy
• Nadine Abi Jaoudeh, MD, FSIR, CCRP, University of California Irvine, USA
• Nora Tabori, MD, MedStar Washington Hospital Center, USA
• Laura Crocetti, Prof., MD, PhD, University of Pisa School of Medicine, Italy

Immuno Oncology

Moderators: Muneeb Ahmed, MD, Beth Israel Deaconess Medical Center/Harvard, USA; S. Nahum Goldberg, MS, FSIR, Hadassah Hebrew University Medical Center, Israel

• Immuno Oncology: Checkpoint inhibitors and beyond, Antonia Digklia, MD, MSc, Centre Hospitalier Universitaire Vaudoise CHUV, Switzerland
• Role of IO in Immuno Oncology, Erica Alexander, MD, Memorial Sloan Kettering Cancer Center, USA
• Manipulating the Tumor Microenvironment, Alda Tam, MD, MD Anderson Cancer Center, USA
• Imaging the Immune Response, Jessica Santana, PhD Student, Yale University, USA
• Immunoadjuvants: The role of percutaneous delivery, Rahul Sheth, MD, MD Anderson Cancer Center, USA

Applied Immuno Oncology

Moderators: Stephen Hunt, MTR, MD, PhD, University of Pennsylvania, USA; Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center, USA

• Bench to Bedside: Lung, Florian J. Fintelmann, MD, Massachusetts General Hospital, USA
• IRE to Improve Tumor Microenvironments and Checkpoint Sensitivity in Pancreatic Cancer, Jayanth Shankara Narayanan, PhD, UCSD, USA
• IA CAR T-cell in Metastatic Colorectal Disease, Gregory Nadolski, MD, University of Pennsylvania, USA
• Bench to Bedside: Liver, Muneeb Ahmed, MD, Beth Israel Deaconess Medical Center/Harvard, USA
• Nanoparticles as Immunoadjuvants and Trojan Horses, Nicole Steinmetz, PhD, UCSD, USA

Getting Started

Moderators: David Breen, MD, University Hospital Southampton, UK; Jack Jennings, MD, PhD, Washington University, USA

• IRE, Ronald Arellano, MD, Massachusetts General Hospital, USA
• Chemosaturation, Brian Stedman, Consultant Interventional Radiologist, University Hospital Southampton, UK
• Injectable Intra-tumoral Treatments, Rahul Sheth, MD, MD Anderson Cancer Center, USA
• Cementoplasty, Francois H. Cornelis, MD, PhD, Memorial Sloan Kettering Cancer Center, USA
• Problem Lymph Node Ablations, Philippe Pereira, MD, SLK Kliniken, Germany
• Thyroid Ablation, Laura Crocetti, Prof., MD, PhD, University of Pisa School of Medicine, Italy

Pancreaticobiliary

Moderators: Sarah White, Medical College of Wisconsin, USA; Rony Avritscher, University of Texas MD Anderson Cancer Center, USA

• Advances in Pancreatic Cancer Treatment: A surgeon's perspective, Flavio Rocha, Oregon Health and Science University, USA
• Local Interventions for Advanced Pancreatic Carcinoma in the Era of Immunotherapy, Martijn Meijerink, Amsterdam UMC, Netherlands
• Cholangiocarcinoma: An overview of novel actionable mutations, Bruno Odisio, The University of Texas MD Anderson Cancer Center, USA
• Is TARE Superior to TACE for Unresectable Cholangiocarcinoma: An in-depth analysis, Christina Mosconi, IRCCS, Policlinico Sant’orsola Hospital, Italy
• Palliative Treatment with Radiation-emitting Metallic Stents in Unresectable Hilar Cholangiocarcinoma, Gao-Jun Teng, Department of Interventional Radiology & Vascular Surgery, Zhongda Hospital, Southeast University, China

MSK Mets

Moderators: Matthew Callstrom, MD, PhD, Mayo Clinic, USA; Afshin Gangi, MD, University Hospital of Strasbourg, France/King’s College London, UK 

• Bone and Soft Tissue Biopsies of Metastatic Disease: Tips and tricks for the challenging cases, Travis Hillen, MD, Washington University School of Medicine St. Louis, USA
• Treatment of Pathologic Fractures of the Spine: Vertebral augmentation from cement to implants, Alexis Kelekis, MD, PhD, EBIR, FCIRSE, FSIR, National and Kapodistrian University of Athens, Greece
• The Role of Bone Ablation for Local Tumor Control, Lindsay Stratchko, DO, University of Wisconsin, USA
• Treatment of Extra-spinal Pathologic Fractures: Percutaneous osteoplasty from cement to screws and implants, Frederic Deschamps, MD, PhD, Gustave Roussy, France
• Complications of Percutaneous Ablation: How to minimize and avoid, Matthew Callstrom, MD, PhD, Mayo Clinic, USA

mCRC

Moderators: Alban Denys, Pr., CHUV University of Lausanne, Switzerland; Costi Sofocleous, MD, PhD, Weill-Cornell Medical College/Memorial Sloan Kettering Cancer Center, USA

• Actionable Mutations: The geography of mCRC, Antonia Digklia, MD, MSc, Centre Hospitalier Universitaire Vaudoise CHUV, Switzerland
• Vanishing Metastases: Resect, ablate, wait?, Martijn Meijerink, MD, PhD, Amsterdam UMC, Netherlands
• Is Surgical Wedge Resection Still the Gold Standard?, Brendan Visser, MD, Stanford University, USA
• Ablation of mCRC: Effectiveness?, Costi Sofocleous, MD, PhD, Weill-Cornell Medical College/Memorial Sloan Kettering Cancer Center, USA
• FLR Assessment: How to, David Madoff, MD, Yale School of Medicine, USA 
• Double Venous Deprivation: Really?, Boris Guiu, MD, PhD, Montpellier University Hospital, France
• Radioembolization: Current best utilization, Daniel Brown, MD, Vanderbilt University Medical Center, USA

SIO Meets KSIR: Current Status of Interventional Treatment of HCC in Korea

Moderators: Chang Won Kim, KSIR Vice President, Pusan National University, Korea; Uei Pua, MBBS, Tan Tock Seng Hospital, Singapore

• Introduction to KSIR, Chang Won Kim, KSIR Vice President, Pusan National University, Korea
• Chemoembolization, In Joon Lee, MD, PhD, National Cancer Center, Korea
• Radioembolization, Hyo-Cheol Kim, PhD, Seoul National University Hospital, Korea
• Ablation Therapy, Dong Ho Lee, MD, MS, Seoul National University Hospital, Korea

mCRC Tumor Board

Moderators: Alban Denys, Pr., CHUV University of Lausanne, Switzerland; Costi Sofocleous, MD, PhD, Weill-Cornell Medical College/Memorial Sloan Kettering Cancer Center, USA;

Case Discussions:

• Antonia Digklia, MD, MSc, Centre Hospitalier Universitaire Vaudoise CHUV, Switzerland
• Martijn Meijerink, MD, PhD, Amsterdam UMC, Netherlands
• Brendan Visser, MD, Stanford University, USA
• David Madoff, MD, Yale School of Medicine, USA
• Boris Guiu, MD, PhD, Montpellier University Hospital, France
• Daniel Brown, MD, Vanderbilt University Medical Center, USA

Scientific Oral Abstracts - SIO Debut Presentations

AI

Moderators: Julius Chapiro, MD, PhD, Assistant Professor of Radiology and Biomedical Imaging, Interventional Oncology Lab, Yale University School of Medicine, USA; Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center, USA

• What is AI?, Krishna Nand Keshava Murthy, PhD, Memorial Sloan Kettering Cancer Center, USA
• AI Problems and Direction of Travel, Julius Chapiro, MD, PhD, Assistant Professor of Radiology and Biomedical Imaging, Interventional Oncology Lab, Yale University School of Medicine, USA
• Using Deep Learning to Address the Response to Image-guided Intervention, Harrison Bai, MD, Johns Hopkins University, USA
• Working with Industry to Facilitate AI Research, Thomas Clozel, MD, Owkin, USA
• Implementing AI into Your IR Practice, Dania Daye, MD, PhD, Massachusetts General Hospital/Harvard Medical School, USA

Lung Mini Master Class

Moderator: Robert Suh, Clinical Professor, Radiological Sciences, David Geffen School of Medicine at UCLA, USA

• Complication: Great saves, Robert Suh, Clinical Professor, Radiological Sciences, David Geffen School of Medicine at UCLA, USA
• Complication: Disasters, Fereidoun Abtin, MD, UCLA Medical Center, USA
• Biopsy and Ablation: Simultaneous and sequential best techniques, Thierry de Baere, MD, Gustave Roussy, France
• Freeze: When, why, and where?, Peter John Littrup, MD, Ascension Providence Rochester Hospital, USA
• Burn: When, why, and where?, Stephen Solomon, MD, Memorial Sloan Kettering Cancer Center, USA

Breaking Ground

Moderators: Stephen Solomon, MD, Memorial Sloan Kettering Cancer Center, USA; Sarah White, MD, MS, Medical College of Wisconsin, USA

• Pediatric Liver IO, Allison Aguado, MD, Nemours Children's Hospital, Delaware, USA
• Breast IO: Where are we?, Yolanda Bryce, MD, Memorial Sloan Kettering Cancer Center, USA
• Initiating MR-guided programs, David Woodrum, MD, PhD, Mayo Clinic, USA

Midgut mNET with NANETS

Moderators: Rony Avritscher, MD, University of Texas MD Anderson Cancer Center, USA; Michael Soulen, MD, FSIR, FCIRSE, Abramson Cancer Center, University of Pennsylvania, USA

• Medical and Surgical Therapy Landscape for Well-differentiated NET Liver Metastases in 2022, Emily Bergsland, MD, UCSF, USA
• Peptide Receptor Radionuclide Therapy: A primer for interventional radiologists, Ghassan El-Haddad, MD, Moffitt Cancer Center and Research Institute, USA
• Liver-directed Therapy Before and After PRRT, Nicholas Fidelman, MD, UCSF, USA
• Radioembolization in the Era of PRRT, Etay Ziv, MD, PhD, Memorial Sloan Kettering Cancer Center, USA
• Staying Out of Trouble: Tips for prevention of carcinoid crisis and other hormone-mediated side effects, Rony Avritscher, MD, University of Texas MD Anderson Cancer Center, USA

MSK Sarcoma

Moderators: Jack Jennings, MD, PhD, Washington University, USA; Afshin Gangi, MD, University Hospital of Strasbourg, France/King’s College London, UK

• Combining Systemic and Local Therapy for Sarcoma MSK Metasteses, Brian Schulte, MD, UCSF, USA
• Ablation and Other Palliative Techniques for Painful Sarcoma Lesions, Roberto Luigi Cazzato, Associate Professor, University Hospital of Strasbourg, France
• Percutaneous Ablation in Oligometastatic MSK Sarcoma for Local Tumor Control, Jack Jennings, MD, PhD, Washington University, USA
• Percutaneous Ablation for Desmoids: What is the evidence?, Afshin Gangi, MD, University Hospital of Strasbourg, France/King’s College London, UK
• What is the Role of HIFU for the Treatment of Sarcomas and Desmoids?, Karun Sharma, MD, PhD, Children's National Hospital & George Washington University, USA

Residents to Experts

Moderators: Vijay Ramalingam, MD, Beth Israel Deaconess Medical Center, USA; Evan Lehrman, MD, FSIR, UCSF, USA; Sarah White, MD, MS, Medical College of Wisconsin, USA; David Breen, MD, University Hospital Southampton, USA

• Direct RFA of Portal Vein Tumor Thrombus in Continuity with HCC, Ioanna Thanou, Resident, Sotiria General Hospital of Athens, Greece
• Siatico-Neoplastic Balloon Adhesioplasty Enabling Limb-sparing Tumor Cryoablation, Matthew Ramsay, IR Fellow, Duke University Medical Center, USA
• Embolization of Large Arterio-bronchial Fistula Due to Metastatic Breast Cancer, Jonathon Weber, MD, University of Kentucky, USA
• Inoperable Tumor-induced Osteomalacia, Hoowan Lee, MD, National Institutes of Health Intramural Research Program, USA
• IO for Complex HCC, Lynne Martin, IR/DR PGY5, Stanford University, USA

Industry Symposium

Lung

Moderators: Damian Dupuy, MD, FACR, Cape Cod Hospital, USA

• Updates on Lung Cancer Surgery, Jay M. Lee, MD, Chief Division of Thoracic Surgery, UCLA Health, USA
• Imaging Evaluation Workup Pre- and Post-ablation, Florian J. Fintelmann, MD, Massachusetts General Hospital, USA
• When SBRT and When Not for Lung Tumors?, Andreas Rimner, Associate Attending, Director of Thoracic Radiation Oncology Research, Memorial Sloan Kettering Cancer Center, USA
• Current State of Interventional Pulmonology and Early Stage Lung Cancer, Eric J. Seeley, MD, UCSF, USA
• Current Guidelines for NSCLC and Oligometastatic Disease to the Lungs, Scott J. Genshaft, MD, UCLA, USA
• Combination Approach to Treating Lung Cancer Patients, Damian Dupuy, MD, FACR, Cape Cod Hospital, USA

Optimized TACE Mini Master Class

Moderators: Michael Soulen, MD, FSIR, FCIRSE, Abramson Cancer Center, University of Pennsylvania, USA; Sarah White, MD, MS, Medical College Wisconsin, USA; Nishita Kothary, MBBS, FSIR, Stanford University, USA

• Optimal Preparation and Treatment Endpoints in cTACE, Sarah White, MD, MS, Medical College Wisconsin, USA
• Drug Recommendations for TACE, R. Peter Lokken, MD, MPH, FSIR, UCSF, USA
• How to Improve Local Tumor Control in Super-selective cTACE, Toshihiro Tanaka, Tokyo Medical and Dental University, Japan
• Determining the Ideal Bead Size for Embolization, Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center, USA
• TACE via Extrahepatic Collaterals: Safety considerations, Kristen Lee, MD, Singapore General Hospital, Singapore
• Hands-on Equipment Showcase, All panelists

"How I Do It" Video Session

Moderators: Vijay Ramalingam, MD, Beth Israel Deaconess Medical Center, USA; Steven Yevich, MD, MPH, University of Texas MD Anderson Cancer Center, USA

• Complex Pelvic Instrumentation, Frederic Deschamps, MD, PhD, Gustave Roussy, France
• Lymphatic Intervention, Gregory Nadolski, MD, University of Pennsylvania, USA
• Venous Intervention for Palliation in SVC Syndrome/Lower Extremity Edema, Evan Lehrman, MD, FSIR, UCSF, USA
• Complex Renal Cryoablation (T1B > 4 cm), Ryan Michael Kohlbrenner, MD, UCSF, USA
• Chemosaturation, Brian Stedman, Consultant Interventional Radiologist, University Hospital Southampton, UK

Meet the Researchers Forum

Moderators: Alda Tam, MD, MD Anderson Cancer Center, USA; Michael Soulen, MD, FSIR, FCIRSE, Abramson Cancer Center, University of Pennsylvania, USA 

• RETNET (Neuroendocrine carcinoma, cTACE vs. bland embolization), Michael Soulen, MD, FSIR, FCIRSE, Abramson Cancer Center, University of Pennsylvania, USA
• COLLISION Trial (Colorectal ablation vs surgery), Martijn Meijerink, MD, PhD, Amsterdam UMC, Netherlands
• COVERALL Trial (Software-aided imaging to increase tumor coverage during ablation), Bruno Odisio, MD, FSIR, The University of Texas MD Anderson Cancer Center, USA
• iHEPAR Trial (HCC treatment with individualized approach using holmium-166), Marnix Lam, MD, PhD, University Medical Center Utrecht, Netherlands
• EMERALD-1 (HCC treated with TACE + immune checkpoint blockade), Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center, USA

Scientific Oral Abstracts & Awards Presentation

*Social Event - SIO 5 Year Anniversary Celebration

* a separate fee is required to attend the Social Event

Renal

Moderators: David Breen, MD, University Hospital Southampton, UK; Grant Schmit, MD, Mayo Clinic, USA

• Indolent Renal Cell Cancer: When to resect, ablate or wait?, Maxwell Meng, MD, UCSF, USA
• Inheritable Renal Cancer Syndromes, Joyce So, MD, PhD, FRCPC, FCCMG, UCSF, USA
• Ablation of RCC: Current status, Grant Schmit, MD, Mayo Clinic, USA
• Awkward RCC Ablation, Brian Welch, MD, Mayo Clinic, USA
• Loco-regional Treatments for Metastatic RCC, Dimitrios Filippiadis, MD, PhD, MSc, EBIR, University of Athens, Greece

Prostate

Moderators: David Woodrum, MD, PhD, Mayo Clinic, USA; Eric M. Walser, MD, University of Texas Medical Branch, USA

• Focal Therapy of Prostate: Why, when, how much?, Dan Sperling, MD, DABR, Sperling Prostate Center, USA
• Focal Therapies: MR- vs. US-guided, Eric M. Walser, MD, University of Texas Medical Branch, USA 
• Best Energies in Prostate Ablation, David Woodrum, MD, PhD, Mayo Clinic, USA
• MR/US Fusion-guided HIFU of Prostate Cancer, Afshin Gangi, MD, University Hospital of Strasbourg, France/King's College, UK
• Prostate Cancer Focal Therapy: Today and tomorrow, Tim Dudderidge, MBChB, MSc, FRCS, Urol, University Hospital Southampton, UK

Palliative Care: Multidisciplinary Approach

Moderators: Nicholas Fidelman, MD, UCSF, USA; Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center, USA

• Symptom Management Service, Michael Rabow, UCSF, USA
• Nerve Blocks for Pain Palliation, Louis-Martin Boucher, MD, PhD, McGill University, Canada
• Gastric Decompression, Steven Huang, MD, The University of Texas MD Anderson Cancer Center, USA
• Advanced Endoscopy Techniques, Jeffrey Chick, MD, MPH, University of Washington, USA
• Venous Flow Restoration, K. Pallav Kolli, MD, UCSF, USA

President's Closing Remarks

SIO President, Matthew Callstrom, MD, PhD, Mayo Clinic, USA